The Effect of DPT-1 Intravenous Insulin Infusion and Daily Subcutaneous Insulin on Endogenous Insulin Secretion and Postprandial Glucose Tolerance.

Diabetes Care 2015 May 26;38(5):891-6. Epub 2015 Feb 26.

Department of Medicine, Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA Department of Veterans Affairs, Puget Sound Health Care System, Seattle, WA.

Objective: To investigate the effect of parenteral insulin therapy on endogenous insulin secretion in the Diabetes Prevention Trial-Type 1 (DPT-1).

Research Design And Methods: In the parenteral insulin arm of DPT-1, subjects without diabetes at high risk of future type 1 diabetes randomized to active treatment received a yearly 4-day intravenous insulin infusion (IV-I) and daily subcutaneous insulin (SC-I). To examine the effects of these insulin therapies on endogenous insulin secretion, C-peptide and glucose levels were compared during oral glucose tolerance tests (OGTTs) performed on and off IV-I and SC-I. Forty-six paired OGTTs were performed in 30 subjects from DPT-1 to determine the effect of IV-I. Twenty paired OGTTs were performed in 15 subjects from DPT-1 to determine the effect of SC-I.

Results: IV-I suppressed fasting and OGTT-stimulated C-peptide (62% and 40%, respectively), and it significantly lowered fasting glucose (67.4 ± 4.5 mg/dL during IV-I vs. 90.9 ± 1.8 mg/dL off insulin; P < 0.05). By contrast, post-OGTT glucose levels were significantly higher during IV-I: Glucose during IV-I versus off insulin at 120 min was 203.9 ± 15.1 vs. 151.6 ± 10.2 mg/dL, respectively (P < 0.05); 49% of OGTTs became transiently diabetic (>200 mg/dL at 120 min) when receiving IV-I. Fasting glucose was significantly lower when receiving SC-I versus when off insulin (85 ± 3 vs. 94 ± 2 mg/dL, respectively; P < 0.05), but SC-I did not significantly alter fasting or OGTT-stimulated C-peptide compared with being off insulin.

Conclusions: These data demonstrate that the IV-I used in the DPT-1 markedly suppressed endogenous insulin secretion, which was frequently associated with postprandial glucose intolerance. SC-I, however, did not.

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc14-1825DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407749PMC
May 2015
3 Reads

Publication Analysis

Top Keywords

endogenous insulin
16
insulin secretion
16
insulin
14
ogtts performed
12
iv-i
9
parenteral insulin
8
glucose levels
8
glucose tolerance
8
performed subjects
8
dpt-1 determine
8
versus insulin
8
120 min
8
mg/dl 005
8
fasting glucose
8
ogtt-stimulated c-peptide
8
postprandial glucose
8
fasting ogtt-stimulated
8
subjects dpt-1
8
paired ogtts
8
glucose
8

Similar Publications